Related Experiment Video
Updated: Nov 14, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
The Cardiovascular Effects of Electronic Cigarettes
Saroj Khadka1, Manul Awasthi2, Rabindra Raj Lamichhane3
1Department of Medicine, Division of Cardiology, East Tennessee State University, 329 N State of Franklin Rd, Johnson City, TN, 37604, USA.
Electronic cigarette use is increasing, especially among youth, despite claims of safety. Studies indicate potential cardiovascular risks from e-cigarette constituents like nicotine and particulate matter.
Area of Science:
- Cardiovascular Research
- Public Health
- Toxicology
Background:
- Electronic cigarette (e-cigarette) popularity is rising across all age groups, particularly among youth.
- E-cigarettes are marketed as safer alternatives to traditional smoking and as cessation aids.
- Despite declining tobacco use, e-cigarette consumption is increasing, with many users engaging in dual use (e-cigarettes and conventional cigarettes).
Purpose of the Study:
- To review the existing literature on the cardiovascular effects of e-cigarette use.
- To identify potential risks associated with e-cigarette constituents.
- To assess the cardiovascular implications of dual e-cigarette and conventional cigarette use.
Main Methods:
- Literature review of emerging studies and existing research.
- Analysis of e-cigarette constituents and their known toxicological profiles.
- Examination of cardiovascular effects reported in current research.
Main Results:
- E-cigarette use is associated with harmful cardiovascular effects.
- Key constituents like nicotine, carbonyls, and particulate matter pose risks for cardiovascular diseases (CVD).
- A significant portion of e-cigarette users are dual users, increasing potential health risks.
Conclusions:
- Existing evidence suggests e-cigarettes are not benign and carry cardiovascular risks.
- Further clinical studies and randomized trials are needed to fully elucidate the long-term cardiovascular impact.
- The constituents within e-cigarettes present a tangible risk for developing cardiovascular diseases.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Cardiovascular Drugs: Classification based on Therapeutic Indications